AMFI - Registered Mutual Fund Distributor

Corona Remedies Limited IPO

Corona Remedies Limited IPO

₹ 14868 / 14 Shares Shares
Minimum Investment

Corona Remedies Limited IPO

Issues Price

₹1008-1062 per equity share

Corona Remedies Limited IPO

Open Date

08 Dec 2025

Close Date

10 Dec 2025

Lot Size

14

Min. Investment

₹ 14868

Issue Price

₹1008-1062

Listing Date

15 Dec 2025

Issues Size

61,71,101 shares(aggregating up to ₹655.37 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

14 Shares

Offered To Public

14 Shares

Corona Remedies Limited IPO

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.

Founded In

2004

Managing Director

Dr. Kirtikumar Laxmidas Mehta

Parent Organization

Corona Remedies Limited IPO

Application Details of Corona Remedies Limited IPO.

Apply as Price Range Apply Upto
Retail (min) ₹1008-1062 ₹14,868
Retail(max) ₹1008-1062 ₹1,93,284
SHNI(min) ₹1008-1062 ₹2,08,152
SHNI(max) ₹1008-1062 ₹9,96,156
BHNI(min) ₹1008-1062 ₹10,11,024

For Corona Remedies Limited IPO, eligible investors can apply as Regular.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.9 Out of 5 (10924 Reviews)

KSquare helped me choose the right pension fund with detailed comparisons. Their expert team made everything clear.

Karan Mehra

Karan Mehra

IT Solutions Architect

As someone new to investing, KSquare’s SIP guidance has been incredibly helpful. Their platform is user-friendly, and the support team answered all my questions patiently.

Neha Gupta

Neha Gupta

HR Specialist

Thanks to KSquare, my retirement plan feels organized. Their NPS tools and knowledge gave me real confidence in the future.

Tanya Khosla

Tanya Khosla

PR Consultant

I enrolled in NPS through KSquare and found their portal extremely intuitive. Their team guided me at every step.

Shruti Anand

Shruti Anand

UX Researcher

KSquare not only alerts about NFOs, but they explain fund purpose and performance projections. I truly appreciate that extra layer of detail and care.

Aditya Chauhan

Aditya Chauhan

Systems Engineer

KSquare presents each new fund launch with such clarity. Their tools gave me better understanding of sectors and fund outlooks before investing.

Harsh Vardhan

Harsh Vardhan

Energy Analyst

Thanks to KSquare, I’ve finally started saving regularly. Their SIP structure fits my needs, and I feel much more confident about my financial future.

Ritika Shah

Ritika Shah

Pharmacist

KSquare’s New Fund Offering system is reliable and easy to follow. Their pre-launch alerts and fund guides helped me confidently choose what’s best for me.

Divya Jaisingh

Divya Jaisingh

Technical Writer

I never imagined saving for the future could be this easy. KSquare’s SIP service is transparent, reliable, and perfect for professionals like me looking to invest smartly.

Priya Mehta

Priya Mehta

Marketing Manager

I appreciated how KSquare simplified the NPS jargon. Everything was laid out clearly with ongoing support.

Manish Talreja

Manish Talreja

Sales Head

FAQ's

Frequenlty Asked Question

How is the loan amount calculated?

The loan value is based on the mutual fund's NAV and the lender’s margin requirements. KSquare shows your eligible amount during application.

How is SIP different from recurring deposits?

Unlike fixed-interest recurring deposits, SIP returns are market-linked and offer higher growth potential with some risk.

What is the typical duration of an NFO subscription period?

NFOs generally remain open for 7 to 15 days, after which the scheme is closed for subscription until listed.

Why should I consider investing in an NFO through KSquare?

KSquare offers expert analysis, transparent insights, and seamless access to promising NFOs aligned with your goals.

Can I withdraw funds from my NPS account early?

Partial withdrawals of up to 25% are allowed after 3 years for specific purposes like medical emergencies, education, or house purchase.

What are the tax benefits of NPS?

NPS offers deductions up to ₹1.5 lakh under Section 80C and an additional ₹50,000 under Section 80CCD(1B) of the Income Tax Act.

Can I have multiple SIPs for different goals?

Yes, you can set up multiple SIPs with KSquare for various goals like retirement, education, or buying a home.

Can I nominate someone in India for my investments?

Yes, NRIs can nominate any Indian resident for their mutual fund holdings and other financial assets via KSquare.

App Store

Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.